Tracking progress: an update on animal models for Duchenne muscular dystrophy by Dominic J. Wells

Connect to this object online.

Validation of DE50-MD dogs as a model for the brain phenotype of Duchenne muscular dystrophy by Abbe H. Crawford, John C. W. Hildyard, Sophie A. M. Rushing, Dominic J. Wells, Maria Diez-Leon, Richard J. Piercy

Connect to this object online.

Serum inflammatory cytokines as disease biomarkers in the DE50-MD dog model of Duchenne muscular dystrophy by Dominique O. Riddell, John C. W. Hildyard, Rachel C. M. Harron, Natasha L. Hornby, Dominic J. Wells, Richard J. Piercy

Connect to this object online.

Longitudinal assessment of skeletal muscle functional mechanics in the DE50-MD dog model of Duchenne muscular dystrophy by Dominique O. Riddell, John C. W. Hildyard, Rachel C. M. Harron, Frances Taylor-Brown, Joe N. Kornegay, Dominic J. Wells, Richard J. Piercy

Connect to this object online.

Improving translatability of preclinical studies for neuromuscular disorders: lessons from the TREAT-NMD Advisory Committee for Therapeutics (TACT) by Raffaella Willmann, Joanne Lee, Cathy Turner, Kanneboyina Nagaraju, Annemieke Aartsma-Rus, Dominic J. Wells, Kathryn R. Wagner, Cristina Csimma, Volker Straub, Miranda D. Grounds, Annamaria De Luca, Annemieke Aartsma-Rus, James Dowling, Maaike van Putten

Connect to this object online.